Insider Transactions in Q3 2021 at Icosavax, Inc. (ICVX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 02
2021
|
Nano Dimension Iii, L.P. |
BUY
Open market or private purchase
|
Direct |
133,334
+4.42%
|
$2,000,010
$15.0 P/Share
|
|
Aug 02
2021
|
Nano Dimension Iii, L.P. |
BUY
Conversion of derivative security
|
Direct |
2,749,995
+50.0%
|
-
|
|
Aug 02
2021
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
426,393
+50.0%
|
-
|
|
Aug 02
2021
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,666,666
+26.93%
|
$39,999,990
$15.0 P/Share
|
|
Aug 02
2021
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect |
3,112,681
+50.0%
|
-
|
|
Aug 02
2021
|
Adams Street Partners LLC |
BUY
Open market or private purchase
|
Indirect |
133,334
+4.6%
|
$2,000,010
$15.0 P/Share
|
|
Aug 02
2021
|
Adams Street Partners LLC |
BUY
Conversion of derivative security
|
Indirect |
3,259,058
+50.0%
|
-
|
|
Aug 02
2021
|
Terry P Gould Director |
BUY
Open market or private purchase
|
Indirect |
133,334
+4.6%
|
$2,000,010
$15.0 P/Share
|
|
Aug 02
2021
|
Terry P Gould Director |
BUY
Conversion of derivative security
|
Indirect |
3,259,058
+50.0%
|
-
|
|
Aug 02
2021
|
Qiming U.S. Healthcare Fund Ii, L.P. |
BUY
Open market or private purchase
|
Direct |
221,351
+2.0%
|
$3,320,265
$15.0 P/Share
|
|
Aug 02
2021
|
Qiming U.S. Healthcare Fund Ii, L.P. |
BUY
Conversion of derivative security
|
Direct |
3,310,228
+50.0%
|
-
|
|
Aug 02
2021
|
Sanofi > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
66,667
+2.07%
|
$1,000,005
$15.0 P/Share
|
|
Aug 02
2021
|
Sanofi > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,088,502
+50.0%
|
-
|
|
Aug 02
2021
|
Niranjan Kanesa Thasan |
BUY
Open market or private purchase
|
Direct |
6,666
+50.0%
|
$99,990
$15.0 P/Share
|
|
Aug 02
2021
|
Douglas Holtzman Chief Scientific Officer |
BUY
Conversion of derivative security
|
Indirect |
52,440
+50.0%
|
-
|
|
Jul 30
2021
|
Thomas Joseph Russo |
BUY
Grant, award, or other acquisition
|
Direct |
32,500
+50.0%
|
$487,500
$15.0 P/Share
|
|
Jul 30
2021
|
Niranjan Kanesa Thasan |
BUY
Grant, award, or other acquisition
|
Direct |
41,500
+19.75%
|
$622,500
$15.0 P/Share
|
|
Jul 30
2021
|
Adam K. Simpson |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+50.0%
|
$1,875,000
$15.0 P/Share
|
|
Jul 30
2021
|
Heidi Fields |
BUY
Grant, award, or other acquisition
|
Direct |
8,750
+50.0%
|
$131,250
$15.0 P/Share
|
|
Jul 30
2021
|
Douglas Holtzman Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,500
+12.81%
|
$622,500
$15.0 P/Share
|
|
Jul 30
2021
|
Ann M Veneman |
BUY
Grant, award, or other acquisition
|
Direct |
8,500
+50.0%
|
$127,500
$15.0 P/Share
|
|
Jul 30
2021
|
Cassia Cearley |
BUY
Grant, award, or other acquisition
|
Direct |
27,750
+30.61%
|
$416,250
$15.0 P/Share
|
|
Jul 30
2021
|
Charles E Richardson SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
27,750
+26.02%
|
$416,250
$15.0 P/Share
|